Skip to main content
Erschienen in: Heart and Vessels 11/2022

18.05.2022 | Original Article

Efficacy of a phosphodiesterase type 5 inhibitor on the pulmonary artery index and postoperative hemodynamics after a Fontan operation

Erschienen in: Heart and Vessels | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

There have been no reports regarding the influence of a change in the pulmonary artery index before or after a Fontan operation. Moreover, the factors that might affect the change in the pulmonary artery index are unclear. This was a retrospective study, which included 94 patients who underwent a Fontan operation. We divided the patients into two groups according to the change in the pulmonary artery index before and after the Fontan operation: the increased pulmonary artery index group (n = 51) and decreased pulmonary artery index group (n = 43). The pulmonary artery index after the Fontan operation was significantly higher in the increased pulmonary artery index group than decreased pulmonary artery index group (p < 0.0001). The central venous pressure (p < 0.0001) and pulmonary vascular resistance (p = 0.007) were significantly lower in the increased pulmonary artery index group. The mixed venous oxygen saturation was significantly higher in the increased pulmonary artery index group (p < 0.0001). The pulmonary artery index was more increased in the patients who were administered a phosphodiesterase type 5 inhibitor than in those who were not (p = 0.03). The change in the pulmonary artery index reflected the hemodynamics after a Fontan operation during the short term. In that respect, phosphodiesterase type 5 inhibitors might be involved in the process.
Literatur
1.
Zurück zum Zitat Nakata S, Imai Y, Takanashi Y, Kurosawa H, Tezuka K, Nakazawa M, Ando M, Takao A (1984) A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 88:610–619CrossRef Nakata S, Imai Y, Takanashi Y, Kurosawa H, Tezuka K, Nakazawa M, Ando M, Takao A (1984) A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 88:610–619CrossRef
2.
Zurück zum Zitat Adachi I, Yagihara T, Kagisaki K, Hagino I, Ishizaka T, Kobayashi J, Kitamura S, Uemura H (2007) Preoperative small pulmonary artery did not affect the midterm results of Fontan operation. Euro J Cardiothorac Surg 32:156–162CrossRef Adachi I, Yagihara T, Kagisaki K, Hagino I, Ishizaka T, Kobayashi J, Kitamura S, Uemura H (2007) Preoperative small pulmonary artery did not affect the midterm results of Fontan operation. Euro J Cardiothorac Surg 32:156–162CrossRef
3.
Zurück zum Zitat Itatani K, Miyaji K, Nakahata Y, Ohara K, Takamoto S, Ishii M (2011) The lower limit of the pulmonary artery index for the extracardiac Fontan circulation. J Thorac Cardiovasc Surg 142:127–135CrossRef Itatani K, Miyaji K, Nakahata Y, Ohara K, Takamoto S, Ishii M (2011) The lower limit of the pulmonary artery index for the extracardiac Fontan circulation. J Thorac Cardiovasc Surg 142:127–135CrossRef
4.
Zurück zum Zitat Lehner A, Schuh A, Herrmann FEM, Riester M, Pallivathukal S, Dalla-Pozza R, Kozlik-Feldmann R, Netz H, Malec E, Januszewska K (2014) Influence of pulmonary artery size on early outcome after the Fontan operation. Ann Thorac Surg 97:1387–1393CrossRef Lehner A, Schuh A, Herrmann FEM, Riester M, Pallivathukal S, Dalla-Pozza R, Kozlik-Feldmann R, Netz H, Malec E, Januszewska K (2014) Influence of pulmonary artery size on early outcome after the Fontan operation. Ann Thorac Surg 97:1387–1393CrossRef
5.
Zurück zum Zitat Peterson LH, Jensen RE, Parnell J (1960) Mechanical properties of arteries in vivo. Cric Res 8:622–639CrossRef Peterson LH, Jensen RE, Parnell J (1960) Mechanical properties of arteries in vivo. Cric Res 8:622–639CrossRef
6.
Zurück zum Zitat Knott-Craig CJ, Julsrud PR, Schaff HV, Puga FJ, Danielson GK (1993) Pulmonary artery size and clinical outcome after the modified Fontan operation. Ann Thorac Surg 55:646–651CrossRef Knott-Craig CJ, Julsrud PR, Schaff HV, Puga FJ, Danielson GK (1993) Pulmonary artery size and clinical outcome after the modified Fontan operation. Ann Thorac Surg 55:646–651CrossRef
7.
Zurück zum Zitat Girod DA, Rice MJ, Mair DD, Julsrud PR, Puga FJ, Danielson GK (1985) Relationship of pulmonary artery size to mortality in patients undergoing the Fontan operation. Circulation 72:II93-96PubMed Girod DA, Rice MJ, Mair DD, Julsrud PR, Puga FJ, Danielson GK (1985) Relationship of pulmonary artery size to mortality in patients undergoing the Fontan operation. Circulation 72:II93-96PubMed
8.
Zurück zum Zitat Bridges ND, Farrell PE Jr, Pigott JD 3rd, Norwood WI, Chin AJ (1989) Pulmonary artery index. A nonpredictor of operative survival in patients undergoing modified Fontan repair. Circulation 80:I216-221PubMed Bridges ND, Farrell PE Jr, Pigott JD 3rd, Norwood WI, Chin AJ (1989) Pulmonary artery index. A nonpredictor of operative survival in patients undergoing modified Fontan repair. Circulation 80:I216-221PubMed
9.
Zurück zum Zitat Senzaki H, Isoda T, Ishizawa A, Hishi T (1994) Reconsideration of criteria for the Fontan operation. Influence of pulmonary artery size on postoperative hemodynamics of the Fontan operation. Circulation 89:266–271CrossRef Senzaki H, Isoda T, Ishizawa A, Hishi T (1994) Reconsideration of criteria for the Fontan operation. Influence of pulmonary artery size on postoperative hemodynamics of the Fontan operation. Circulation 89:266–271CrossRef
10.
Zurück zum Zitat Kass DA, Takimoto E, Nagayuma T, Champion HC (2007) Phosphodiesterase regulation of the nitric oxide signaling. Cardiovasc Res 75:303–314CrossRef Kass DA, Takimoto E, Nagayuma T, Champion HC (2007) Phosphodiesterase regulation of the nitric oxide signaling. Cardiovasc Res 75:303–314CrossRef
11.
Zurück zum Zitat Wilkins MR, Wharton J, Grimminger F, Ghofrani H (2008) Phosphodiesterase inhibitors in the treatment of pulmonary hypertension. Eur Respir J 32:198–209CrossRef Wilkins MR, Wharton J, Grimminger F, Ghofrani H (2008) Phosphodiesterase inhibitors in the treatment of pulmonary hypertension. Eur Respir J 32:198–209CrossRef
12.
Zurück zum Zitat Archer SL, Michelakis ED (2009) Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 361:1864–1871CrossRef Archer SL, Michelakis ED (2009) Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 361:1864–1871CrossRef
13.
Zurück zum Zitat Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, Newburger JW, Wernovsky G (1997) Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg 114:392–403CrossRef Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, Newburger JW, Wernovsky G (1997) Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg 114:392–403CrossRef
14.
Zurück zum Zitat Fixler DE, Nembhard WN, Salemi JL, Ethen MK, Canfield MA (2010) Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003. Circulation 121:644–650CrossRef Fixler DE, Nembhard WN, Salemi JL, Ethen MK, Canfield MA (2010) Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003. Circulation 121:644–650CrossRef
15.
Zurück zum Zitat Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, Landzberg MJ (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85–92CrossRef Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, Landzberg MJ (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85–92CrossRef
16.
Zurück zum Zitat Hosein RB, Clarke AJ, McGuirk SP, Griselli M, Stumper O, De Giovanni JV, Barron DJ, Brawn WJ (2007) Factors influencing early and late outcome following the Fontan procedure in the current era. The ‘two commandments’? Eur J Cardiothorac Surg 31:344–352CrossRef Hosein RB, Clarke AJ, McGuirk SP, Griselli M, Stumper O, De Giovanni JV, Barron DJ, Brawn WJ (2007) Factors influencing early and late outcome following the Fontan procedure in the current era. The ‘two commandments’? Eur J Cardiothorac Surg 31:344–352CrossRef
17.
Zurück zum Zitat Tunks RD, Barker PCA, Benjamin DK Jr, Cohen-Wolkowiez M, Fleming GA, Laughon M, Li JS, Hill KD (2014) Sildenafil exposure and hemodynamic effect after Fontan surgery. Pediatr Crit Care Med 15(1):28–34CrossRef Tunks RD, Barker PCA, Benjamin DK Jr, Cohen-Wolkowiez M, Fleming GA, Laughon M, Li JS, Hill KD (2014) Sildenafil exposure and hemodynamic effect after Fontan surgery. Pediatr Crit Care Med 15(1):28–34CrossRef
18.
Zurück zum Zitat Reinhardt Z, Uzun O, Bhole V, Ofoe V, Wilson D, Onuzo O, Wright JGC, Stumper O (2010) Sildenafil in the management of the failing Fontan circulation. Cardiol Young 20(5):522–525CrossRef Reinhardt Z, Uzun O, Bhole V, Ofoe V, Wilson D, Onuzo O, Wright JGC, Stumper O (2010) Sildenafil in the management of the failing Fontan circulation. Cardiol Young 20(5):522–525CrossRef
19.
Zurück zum Zitat Rosenthal M, Bush A, Deanfield J, Redington A (1995) Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Circulation 91:372–378CrossRef Rosenthal M, Bush A, Deanfield J, Redington A (1995) Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Circulation 91:372–378CrossRef
20.
Zurück zum Zitat Hjortdal VE, Emmertsen K, Stenbøg E, Fründ T, Schmidt MR, Kromann O, Sørensen K, Pedersen EM (2003) Effects of exercise and respiration on blood flow in total cavopulmonary connection: a real-time magnetic resonance flow study. Circulation 108:1227–1231CrossRef Hjortdal VE, Emmertsen K, Stenbøg E, Fründ T, Schmidt MR, Kromann O, Sørensen K, Pedersen EM (2003) Effects of exercise and respiration on blood flow in total cavopulmonary connection: a real-time magnetic resonance flow study. Circulation 108:1227–1231CrossRef
21.
Zurück zum Zitat Agnoletti G, Gala S, Ferroni F, Bordese R, Appendini L, Napoleone CP, Bergamasco L (2017) Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation. J Thorac Cardiovasc Surg 153:1468–1475CrossRef Agnoletti G, Gala S, Ferroni F, Bordese R, Appendini L, Napoleone CP, Bergamasco L (2017) Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation. J Thorac Cardiovasc Surg 153:1468–1475CrossRef
Metadaten
Titel
Efficacy of a phosphodiesterase type 5 inhibitor on the pulmonary artery index and postoperative hemodynamics after a Fontan operation
Publikationsdatum
18.05.2022
Erschienen in
Heart and Vessels / Ausgabe 11/2022
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02089-w

Weitere Artikel der Ausgabe 11/2022

Heart and Vessels 11/2022 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.